Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: The LIFE study

Author： Reims Henrik   Oparil Suzanne   KJELDSEN Sverre   Devereux Richard   Julius Stevo   Brady William   Fyhrquist Frej   Ibsen Hans   Lindholm Lars   Omvik Per   Wedel Hans   Beevers Gareth   De Faire Ulf   Kristianson Krister   Lederballe-Pedersen Ole   Nieminen Markku   Dahlöf Björn  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.13, Iss.6, 2004-12, pp. : 376-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: The LIFE Study

By Ariansen Inger   Reims Henrik M.   Gjesdal Knut   Olsen Michael Hecht   Ibsen Hans   Devereux Richard B.   Okin Peter M.   Kjeldsen Sverre E.   Dahlöf Björn   Wachtell Kristian  

Blood Pressure, Vol. 21, Iss. 1, 2012-02 ,pp. : 6-11

Informa Healthcare

Access to resources Recommend Favorite

Echocardiographic Left Ventricular Geometry in Hypertensive Patients with Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study

By Devereux Richard B.   Bella Jonathan   Boman Kurt   Gerdts Eva   Nieminen Markku S.   Rokkedal Jens   Papademetriou Vasilios   Wachtell Kristian   Wright Jackson   Paranicas Mary   Okin Peter M.   Roman Mary J.   Smith Gunnar   Dahlöf Björn  

Blood Pressure, Vol. 10, Iss. 2, 2001-04 ,pp. : 74-82

Informa Healthcare

Access to resources Recommend Favorite

Effects of angiotensin II receptor blockade‐based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients

By Cuspidi Cesare   Meani Stefano   Valerio Cristiana   Fusi Veronica   Sala Carla   Maisaidi Meilikemu   Zanchetti Alberto  

Blood Pressure, Vol. 15, Iss. 2, 2006-04 ,pp. : 107-115

Informa Healthcare

Access to resources Recommend Favorite

Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study

By Kjeldsen Sverre E.   Devereux Richard B.   Hille Darcy A.   Lyle Paulette A.   Dahlöf Björn   Julius Stevo   Edelman Jonathan M.   Snapinn Steven M.   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Lederballe-Pedersen Ole   Lindholm Lars H.   Nieminen Markku S.   Omvik Per   Oparil Suzanne   Wedel Hans    

Blood Pressure, Vol. 18, Iss. 6, 2009-12 ,pp. : 348-361

Informa Healthcare

Access to resources Recommend Favorite

Blood Viscosity, Plasma Adrenaline and Fasting Insulin in Hypertensive Patients with Left Ventricular Hypertrophy: ICARUS, a LIFE Substudy

By HØIEGGEN AUD   FOSSUM EIGIL   NESBITT SHAWNA D.   PALMIERI VITTORIO   KJELDSEN SVERRE E.   MOLVIG MERETE BAKKEN   NUELAND AGATHE  

Blood Pressure, Vol. 9, Iss. 2-3, 2000-08 ,pp. : 83-90

Informa Healthcare

Access to resources Recommend Favorite